American Cannabis Company (AMMJ) Ratios
American Cannabis Company Ratios
AMMJ's free cash flow for Q2 2024 was $30.77K. For the 2024 fiscal year, AMMJ's free cash flow was decreased by $-3.00 and operating cash flow was $30.77K. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.42 | 0.49 | 0.53 | 7.14 | 3.59 |
| Quick Ratio | 0.14 | 0.32 | 0.38 | 6.90 | 3.42 |
| Cash Ratio | 0.01 | 0.06 | 0.35 | 6.60 | 2.91 |
| Solvency Ratio | -1.21 | -0.15 | -0.64 | -1.98 | -0.91 |
| Operating Cash Flow Ratio | -0.02 | -0.09 | -0.50 | -2.01 | -0.32 |
| Short-Term Operating Cash Flow Coverage | -0.14 | -0.36 | -0.87 | -4.78 | -2.94 |
| Net Current Asset Value | $ -1.93M | $ -1.72M | $ -1.09M | $ 1.60M | $ 839.55K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.41 | 0.28 | 0.28 | 0.06 | 0.03 |
| Debt-to-Equity Ratio | 748.33 | 0.70 | 0.56 | 0.07 | 0.04 |
| Debt-to-Capital Ratio | 1.00 | 0.41 | 0.36 | 0.06 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 1.00 | 0.07 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1825.21 | 2.47 | 1.99 | 1.16 | 1.37 |
| Debt Service Coverage Ratio | -7.99 | -0.52 | -1.08 | -4.63 | -8.44 |
| Interest Coverage Ratio | -33.90 | -7.76 | -21.77 | -349.38 | 0.00 |
| Debt to Market Cap | 0.64 | 0.29 | 0.20 | 0.03 | 0.01 |
| Interest Debt Per Share | 0.01 | 0.02 | 0.02 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.34 | -3.62 | -0.41 | 3.12 | 3.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 42.08% | 13.49% | 43.55% | 45.90% | 62.83% |
| EBIT Margin | -143.26% | -2.95% | -56.25% | -33.82% | -14.17% |
| EBITDA Margin | -133.48% | -1.74% | -52.29% | -32.93% | -13.84% |
| Operating Profit Margin | -155.53% | -3.22% | -67.67% | -39.75% | -15.67% |
| Pretax Profit Margin | -147.82% | -3.37% | -59.34% | -33.89% | -14.17% |
| Net Profit Margin | -147.82% | -3.37% | -59.34% | -33.89% | -14.17% |
| Continuous Operations Profit Margin | -147.82% | -3.37% | -59.34% | -33.89% | -14.17% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 95.04% | 104.46% | 87.69% | 85.26% | 90.42% |
| Return on Assets (ROA) | -129.37% | -13.71% | -34.07% | -28.17% | -25.08% |
| Return on Equity (ROE) | -236129.03% | -33.86% | -67.91% | -32.69% | -34.33% |
| Return on Capital Employed (ROCE) | -582.11% | -24.08% | -71.54% | -38.35% | -37.97% |
| Return on Invested Capital (ROIC) | -331.57% | -19.33% | -47.02% | -35.92% | -35.18% |
| Return on Tangible Assets | -204.34% | -30.72% | -96.44% | -28.17% | -25.08% |
| Earnings Yield | -341.88% | -26.37% | -25.86% | -12.97% | -5.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.57 | 40.09 | 214.30 | 62.91 | 22.28 |
| Payables Turnover | 1.42 | 23.96 | 5.64 | 64.55 | 81.23 |
| Inventory Turnover | 2.45 | 46.10 | 4.91 | 13.61 | 14.85 |
| Fixed Asset Turnover | 2.80 | 20.49 | 5.14 | 63.68 | 53.22 |
| Asset Turnover | 0.88 | 4.07 | 0.57 | 0.83 | 1.77 |
| Working Capital Turnover Ratio | -2.11 | -18.90 | 7.05 | 1.29 | 2.32 |
| Cash Conversion Cycle | -73.50 | 1.79 | 11.28 | 26.97 | 36.47 |
| Days of Sales Outstanding | 34.54 | 9.10 | 1.70 | 5.80 | 16.38 |
| Days of Inventory Outstanding | 149.21 | 7.92 | 74.28 | 26.82 | 24.58 |
| Days of Payables Outstanding | 257.26 | 15.24 | 64.70 | 5.65 | 4.49 |
| Operating Cycle | 183.75 | 17.02 | 75.99 | 32.63 | 40.96 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.02 | -0.01 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -1.09 | -1.92 | -2.62 | -235.47 | -2.67 |
| Capital Expenditure Coverage Ratio | -1.09 | -1.92 | -2.62 | -235.47 | -2.67 |
| Operating Cash Flow Coverage Ratio | -0.04 | -0.15 | -0.80 | -4.78 | -2.94 |
| Operating Cash Flow to Sales Ratio | -0.02 | -0.01 | -0.40 | -0.33 | -0.05 |
| Free Cash Flow Yield | -7.65% | -12.61% | -23.79% | -12.87% | -2.78% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.29 | -3.79 | -3.87 | -7.71 | -16.84 |
| Price-to-Sales (P/S) Ratio | 0.43 | 0.13 | 2.30 | 2.61 | 2.39 |
| Price-to-Book (P/B) Ratio | 690.67 | 1.28 | 2.63 | 2.52 | 5.78 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.07 | -7.93 | -4.20 | -7.77 | -35.98 |
| Price-to-Operating Cash Flow Ratio | -25.02 | -12.06 | -5.81 | -7.80 | -49.46 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.06 | -0.04 | 0.96 | 0.37 |
| Enterprise Value Multiple | -0.67 | -10.94 | -4.80 | -4.82 | -14.16 |
| Enterprise Value | 2.21M | 3.59M | 6.09M | 2.49M | 4.18M |
| EV to EBITDA | -0.67 | -10.94 | -4.80 | -4.82 | -14.16 |
| EV to Sales | 0.89 | 0.19 | 2.51 | 1.59 | 1.96 |
| EV to Free Cash Flow | -26.98 | -11.85 | -4.60 | -4.72 | -29.54 |
| EV to Operating Cash Flow | -51.63 | -18.03 | -6.36 | -4.74 | -40.61 |
| Tangible Book Value Per Share | -0.01 | -0.01 | -0.01 | 0.03 | 0.02 |
| Shareholders’ Equity Per Share | 0.00 | 0.02 | 0.03 | 0.03 | 0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.02 | 0.22 | 0.03 | 0.03 | 0.04 |
| Net Income Per Share | -0.03 | -0.01 | -0.02 | -0.01 | -0.01 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.03 | 1.14 | 1.05 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 1.37 | 0.15 | 0.86 | 0.66 | 0.53 |
| Stock-Based Compensation to Revenue | 0.70 | 0.01 | 0.02 | 0.02 | 0.03 |
| Income Quality | 0.01 | 0.31 | 0.67 | 0.99 | 0.34 |
Currency in USD